Market Cap
$4.3B
CNK
Cinemark Holdings, Inc.
$36.05 ▼ -0.36%
Prev close $36.18Market cap$4.3B
ConsensusBuy
12-mo target$39.82 (+10.5%)
▲ Bullish
Analyst conviction 7/10
High Impact Filing (8/10)17 New Institutional Positions22 Institutional Exits Media & Telecom
Snapshot
The big-picture read on CNK right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Buy (65%)
Inst. Holders
50 funds
Inst. Value
$3.0B
Inst. Activity
17 buys / 22 sells
Insider Activity
$0.00 buy / $4.4M sell
Insider Net $
-$4.4M
Social Sentiment
80° Bullish
SEC Reports
3
Price chart 30d +3.0%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Short Volume: CNK — 62.1% short (0.5M / 0.8M)
Short: 466,709 | Exempt: 503 | TRF Vol: 751,404 | Short Ratio: 62.1% | Off-exchange volume (dark poo
Sep 25, 2026 Insider
Fernandes Valmir disposed of 38,000 shares
Pr - Cinemark International @ $38.00 ($1.4M)
Sep 11, 2026 Insider
Fernandes Valmir disposed of 20,000 shares
Pr - Cinemark International @ $35.17 ($703.4K)
Sep 1, 2026 Insider
Jul 30, 2026 SEC Cavalier Michael disposed of 107,296 shares
EVP-General Counsel @ $35.02 ($3.8M)
Cinemark reported record Q2 2026 results with all-time high quarterly revenue of $1.086B, up 15.5% YoY, and EPS of $1.19
8-K — Impact 8/10
Jun 30, 2026 Inst.
Woodline Partners LP — ADD
2,236,932 shares ($71.0M)
Jun 30, 2026 Inst.
Jun 9, 2026 SEC Qube Research & Technologies — DOUBLED
1,614,095 shares ($51.2M)
Cinemark CMO Wanda Marie Gierhart filed a Form 144 to sell 23,456 shares valued at ~$750,592 through Charles Schwab. The
144 — Impact 3/10
Analyst ratings buy % -8.5%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
65% rate it Buy or better · 17 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 24, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight | 55% |
| Sep 2, 2026 | Macquarie | MAINTAIN | Outperform | 55% |
| Aug 14, 2026 | JP Morgan | DOWNGRADE | Neutral | 55% |
| Jul 31, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| Jul 31, 2026 | B. Riley Securities | MAINTAIN | Neutral | 54% |
| Jul 31, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Jul 31, 2026 | Benchmark | MAINTAIN | Buy | 54% |
| Jul 31, 2026 | Wedbush | MAINTAIN | Outperform | 57% |
| Jul 30, 2026 | Macquarie | MAINTAIN | Outperform | 55% |
| Jul 29, 2026 | Wedbush | MAINTAIN | Outperform | 57% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 3 | 8 | 6 | 0 | 0 | 65% | |
| Aug 1, 2026 | 3 | 9 | 5 | 0 | 0 | 71% | |
| Jul 1, 2026 | 3 | 10 | 3 | 1 | 0 | 76% | |
| Jun 1, 2026 | 3 | 10 | 3 | 1 | 0 | 76% | |
| May 1, 2026 | 3 | 10 | 3 | 1 | 0 | 76% | |
| Apr 1, 2026 | 3 | 10 | 3 | 1 | 0 | 76% | |
| Mar 1, 2026 | 3 | 10 | 3 | 1 | 0 | 76% | |
| Feb 1, 2026 | 3 | 9 | 4 | 1 | 0 | 71% |
Price targets
Where 11 covering analysts think CNK trades over the next 12 months.
$39.82 +10.5% upside Buy
Current$36.05 Low$34.00 Median$40.00 High$44.00 11 analysts
$34.00$44.00
Analyst rating Buy· 2.0/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
80°
Bullish
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
3 SEC filing reports analyzed · 1 bullish, 0 bearish, 0 mixed, 2 neutral · avg impact 4.7/10.
BULLISH8-K8/10
Cinemark reported record Q2 2026 results with all-time high quarterly revenue of $1.086B, up 15.5% Y
Jul 30, 2026
NEUTRAL1443/10
Cinemark CMO Wanda Marie Gierhart filed a Form 144 to sell 23,456 shares valued at ~$750,592 through
Jun 9, 2026
NEUTRALDEFA14A3/10
Cinemark Holdings, Inc. (CNK) has filed its definitive proxy statement for its 2026 annual meeting.
Apr 1, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: CNK — 62.1% short (0.5M / 0.8M)
Short: 466,709 | Exempt: 503 | TRF Vol: 751,404 | Short Ratio: 62.1% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
short_volume
Short Volume: CNK — 61.3% short (0.6M / 1.0M)
Short: 595,804 | Exempt: 0 | TRF Vol: 972,006 | Short Ratio: 61.3% | Off-exchange volume (dark pool + OTC)
Sep 24, 2026
short_volume
Short Volume: CNK — 69.0% short (0.6M / 0.9M)
Short: 602,848 | Exempt: 0 | TRF Vol: 873,396 | Short Ratio: 69.0% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
short_volume
Short Volume: CNK — 67.2% short (0.4M / 0.6M)
Short: 392,457 | Exempt: 0 | TRF Vol: 583,825 | Short Ratio: 67.2% | Off-exchange volume (dark pool + OTC)
Sep 22, 2026
short_volume
Short Volume: CNK — 68.3% short (0.5M / 0.8M)
Short: 523,945 | Exempt: 0 | TRF Vol: 767,311 | Short Ratio: 68.3% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.80 | $0.69–$0.99 | 100.4% | +17.3% | 2↑ 0↓ | $1.0B | 9 |
| Next Q | $0.55 | $0.32–$1.02 | 89.0% | +7.3% | 1↑ 0↓ | $0.9B | 9 |
| Current FY | $2.50 | $2.30–$3.04 | 140.8% | +6.7% | 2↑ 0↓ | $3.6B | 9 |
| Next FY | $2.73 | $2.45–$3.46 | 9.1% | +2.6% | 2↑ 0↓ | $3.7B | 9 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.801 | — |
| 7d ago | $0.801 | — |
| 30d ago | $0.683 | +0.118 |
| 60d ago | $0.680 | +0.121 |
| 90d ago | $0.799 | +0.003 |
Institutional ownership
Which big funds own CNK (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $3.0B total value (94,695,510 shares) as of 2026-Q2. Top holders: BlackRock,, Orbis, WELLINGTON. Net selling activity: 22 institutions trimmed/exited vs 17 added.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 16,730,390 | $530.9M | 17.7% | — |
| Orbis Allan Gray Ltd | 15,057,911 | $477.8M | 15.9% | — |
| WELLINGTON MANAGEMENT GROUP LLP | 7,755,183 | $246.1M | 8.2% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6,507,897 | $206.5M | 6.9% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,703,270 | $149.2M | 5.0% | — |
| STATE STREET CORP | 4,187,921 | $132.9M | 4.4% | — |
| RENAISSANCE TECHNOLOGIES LLC | 3,772,885 | $119.7M | 4.0% | — |
| DIMENSIONAL FUND ADVISORS LP | 2,995,585 | $95.1M | 3.2% | — |
| MILLENNIUM MANAGEMENT LLC | 2,742,473 | $87.0M | 2.9% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 2,639,089 | $83.8M | 2.8% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| Woodline Partners LP | ADD | 1,322,043 | 2,236,932 | +69.2% | $71.0M |
| Qube Research & Technologies Ltd | DOUBLED | 316,698 | 1,614,095 | +409.7% | $51.2M |
| Alyeska Investment Group, L.P. | TRIM | 2,071,953 | 1,168,046 | -43.6% | $37.1M |
| GOLDMAN SACHS GROUP INC | TRIM | 1,832,138 | 1,023,866 | -44.1% | $32.5M |
| UBS Group AG | TRIM | 1,298,388 | 831,672 | -35.9% | $26.4M |
| CITADEL ADVISORS LLC | TRIM | 2,782,986 | 816,339 | -70.7% | $25.9M |
| Connor, Clark & Lunn Investment Management Ltd. | DOUBLED | 250,115 | 714,049 | +185.5% | $22.7M |
| Trexquant Investment LP | ADD | 405,013 | 621,697 | +53.5% | $19.7M |
| D. E. Shaw & Co., Inc. | TRIM | 1,337,279 | 502,521 | -62.4% | $15.9M |
| MARSHALL WACE, LLP | TRIM | 1,239,523 | 480,909 | -61.2% | $15.3M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
17 insiders, 50 transactions. Net -$4.4M — $0.00 bought, $4.4M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Fernandes Valmir | Pr - Cinemark International | D | 38,000 | $38.00 | $1.4M |
| Sep 11, 2026 | Fernandes Valmir | Pr - Cinemark International | D | 20,000 | $35.17 | $703.4K |
| Sep 1, 2026 | Cavalier Michael | EVP-General Counsel | D | 107,296 | $35.02 | $3.8M |
| Aug 31, 2026 | Gamble Sean | Chief Executive Officer | D | 7,191 | $35.99 | $258.8K |
| Aug 24, 2026 | Gamble Sean | Chief Executive Officer | D | 138,884 | $38.19 | $5.3M |
| Aug 20, 2026 | Thomas Melissa | EVP, Chief Financial Officer | D | 38,236 | $37.53 | $1.4M |
| Aug 12, 2026 | Burian Lawrence J. | Director | AWARD | 3,908 | — | — |
| Jul 28, 2026 | Gierhart Wanda Marie | Chief Marketing & Content Ofc | D | 9,450 | $35.00 | $330.8K |
| Jun 15, 2026 | Antonellis Darcy | Director | AWARD | 5,439 | — | — |
| Jun 15, 2026 | CHERESKIN BENJAMIN D | Director | AWARD | 5,439 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for CNK.
Shares short
7,262,674
Settlement Sep 15, 2026
Change vs prior
-14.0%
Semi-monthly cycle
Days to cover
3.5
At avg daily volume
Of shares outstanding
≈6.3%
Estimate — not % of float
All CNK filing & press-release reports (3)
- 8-K reportJul 30, 2026
- 144 reportJun 9, 2026
- DEFA14A reportApr 1, 2026